Cancer Prevention Group Blog

Cancer Prevention Group Blog

Research Today, Cancer Prevention Tomorrow

Cytosponge™

Cancer Prevention Group’s 2021 Christmas reading list

December 19, 2021 Jamie Doorbar 0

It’s that time of year again – to sit back, relax, and get stuck into one of our papers over the festive period! Below are […]

BEST3 – The Participant Perspective

October 22, 2021 Jane Rigney 0

This post is from the BEST3 event website, available here. Stay tuned over the coming weeks for more posts about the results from the BEST3 trial! […]

GP views on implementing the Cytosponge in Primary Care

May 14, 2021 Jane Rigney 0

This post is from the BEST3 event website, available here. Stay tuned over the coming weeks for more posts about the results from the BEST3 trial! […]

Pathology and Artificial Intelligence in BEST3

April 16, 2021 Jane Rigney 0

This post is from the BEST3 event website, available here. Stay tuned over the coming weeks for more posts about the results from the BEST3 trial! […]

Headline findings of the BEST3 Trial

March 26, 2021 Jane Rigney 0

This post is from the BEST3 event website, available here. Stay tuned over the coming weeks for more posts about the results from the BEST3 […]

Cancer Prevention Group’s 2020 Christmas reading list

December 21, 2020 Jamie Doorbar 0

Following the success of our 2019 reading list (available here) we’ve decided to put together a list of 25 publications to celebrate the cancer prevention […]

Best of BEST3: An interview with Rebecca Fitzgerald, Chief Investigator

August 21, 2020 Jamie Doorbar 0

In this post, we interview Rebecca Fitzgerald, chief investigator for the BEST3 trial. Her work at the MRC Cancer Unit focuses on the early detection […]

Best of BEST3: An interview with Irene Debiram-Beecham, clinical coordinator

August 19, 2020 Jamie Doorbar 0

In this post, we interview Irene Debiram-Beecham, clinical coordinator for the BEST3 trial. Irene is a Senior Research Sister in Professor Rebecca’s Fitzgerald’s group and […]

Best of BEST3: a Q&A with Beth Muldrew, Clinical Project Manager

August 7, 2020 Jamie Doorbar 0

In this blog, we interview Beth Muldrew, Clinical Project Manager for the BEST3 trial. Beth successfully managed the project from start-up to conclusion, working across […]

Best of BEST3: A (not so) hard pill to swallow- an overview of BEST3 & the Cytosponge

August 5, 2020 Judith Offman 0

The results of the BEST3 trial have just been published and the findings have exceeded even our most optimistic expectations. This trial showed that the […]

Sponging the oesophagus to detect cancer earlier

July 12, 2019 Jane Rigney 1

We are celebrating the end of recruitment for the BEST3 Cytosponge™ Trial. In this post the BEST3 team in London and Cambridge tell us about this […]

Welcome to the King’s Cancer Prevention blog

This blog is supported by the Early Cancer Institute at the University of Cambridge.

Cancer Prevention: About us

We are a group of epidemiologists and population researchers studying the causes of or early events in the development of cancer. Our aim is to be able to interfere and prevent cancer or diagnose it whilst still easy to treat.

Contact us at cancerprev@kcl.ac.uk

Follow us on Social Media

TWITTER FEED

Tweets by CancerPrev_KCL

Latest Posts, Tags & Comments
  • Cervical Screening and HPV Self-Sampling in Denmark
  • The Pathway to Cervical Cancer Elimination in Australia: An Interview with Megan Smith
  • The Fight for Global Health Equity: Eliminating Cervical Cancer
  • From Unlikely Allies to Global Elimination Strategy: the history of HPV and cervical cancer
  • Cancer Prevention Group’s 2022 Christmas Reading List
  • 5 Mins with: Dr Christian von Wagner
  • 5 Minutes with: Dr Katharine Rendle
  • Using registry data to evaluate early cancer diagnosis initiatives
  • The new UK Institute seeking to detect cancer early enough to cure it
  • EDI Series | Part 1: 5 minutes with..
Barrett’s oesophagus Best 3 Breast cancer screening cancer prevention cancer screening cervical cancer cervical screening Clinical research network COVID-19 Cytosponge™ five minutes with HPV HPV primary screening HPV vaccination mammography medical research Oesophageal cancer public health public policy quality assurance screening self-sampling sensitivity Upper GI Women in Science
  • PTS Terbaik Bandung: Very creative..I like the discussion and writing about this article. Hopefully this article can add insight for readers.
  • Eiram: It's important to work on preventing it. https://lfu.edu.krd/
  • What are women’s views of personalised breast cancer risk assessment and risk-stratified breast screening? – Cancer Prevention Group Blog: […] Autumn, we posted a blog that outlined why the introduction of risk-stratification to the NHS Breast Screening Programme is…
Meta
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Copyright © 2023 | WordPress Theme by MH Themes